We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Webinar Recordings » New Medical Device and In Vitro Diagnostic Regulation in the EU - Webinar CD/Transcript

Other Options

Audio CD/Transcript - March 8, 2017

$287.00

Audio CD/Transcript - March 8, 2017

$258.00

Audio CD/Transcript - March 8, 2017

$244.00

Audio CD/Transcript - March 8, 2017

$230.00

Audio CD/Transcript - March 8, 2017

$215.00

New Medical Device and In Vitro Diagnostic Regulation in the EU - Webinar CD/Transcript

$287.00
Webinar Recordings

Product Details

New Medical Device and In Vitro Diagnostic Regulation in the EU: What You Need to Know to Make the Right EU& US Market Entry Decisions

Following the “scandals” related to metal-on-metal artificial hips and faulty silicone breast implants, the European Commission put forward a draft legislative proposal in 2012 to revise the medical device and in vitro diagnostic regulations to improve patient safety while encouraging medical device innovation.

The Commission intends to do this by:

  • Extending the scope and reclassification of devices and in vitro diagnostics
  • Pre-market scrutiny for high risk devices
  • Reinforced rules for clinical evidence
  • Tightening post-market surveillance
  • Increasing traceability via UDI system to enhance post-market safety requiring manufacturers hire a person responsible for regulatory compliance
  • Strengthening supervision of notified bodies by authorities

While preparing for a more robust regulatory regime in the EU, you must also keep an eye on the FDA in the wake of the U.S. presidential election. The new administration is signaling the need for quick action across all industries and the president campaigned on the importance of clearing up the FDA’s backlog of product approvals.

Join Michael M. Gaba — Life Science Partner, Holland & Knight LLP, USA — and Shayesteh Fürst-Ladani — founder and CEO, SFL Regulatory Affairs & Scientific Communication Ltd., Switzerland — for a discussion on the biggest anticipated changes to the EU and U.S. medical device framework and their impact on global go to market strategies, including the extent to which a company can harmonize its regulatory effort for the global market.

After this 90-minute session you’ll know:

  • How to handle the EU’s expanded pre-market expectations for medical device manufacturers
  • How to prepare for amplified post-market surveillance in the EU
  • What to expect when working with notified bodies under this new regulatory regime
  • The extent to which a company’s regulatory processes in the EU and US can be harmonized
  • What to expect from the FDA’s new legal authorities to influence medical device approvals
  • What factors to consider, including the impact of Brexit, when making your decision about first point of market entry:  EU or US?

Order today and learn what you need to know to make the right EU and U.S. market entry decisions.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing